Lymphatica Medtech SA
Revolution in lymphedema therapy
Lymphatica is a clinical stage medical device development company that has designed and patented the first implantable system for chronic lymphedema treatment, which will improve the quality of life of millions of patients in the world.
Chronic lymphedema is a common side effect of cancer therapies that causes chronic swelling of the limbs, pain and recurrent infections, leading to a state of chronic disability. More than 10 million people in Europe and US have lymphedema.
Lymphatica is a new hope for the patient and a new tool for healthcare specialists.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
09.10.2024
Lymphatica Medical raises €17.9 million in series B Funding (startupticker.ch)
08.10.2024
Lymphatica Medtech raises EUR 17.9M in Series B to advance Lymphedema treatment (venturelab.swiss)
12.02.2024
Lymphatica Medtech awarded FDA Breakthrough Device Designation (startupticker.ch)
24.10.2023
Startups appoint industry mavens to their board of directors (startupticker.ch)
15.06.2023
CHF 1.2M FIT Funding for Imverse, Isochronic & Lymphatica (startupticker.ch)
Last Tweets
11.05.2022
LymphoDrain pilot clinical trial: 3 arm lymphedema patients successfully implanted with our device
13.04.2021
Authorization to run clinical trials
14.04.2019
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders China
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
>>Venture>>
The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.
IMD Startup Competition
The IMD Startup Competition provides an unique opportunity for regional technology startups to benefit from the help and insights of a team of dedicated, experienced IMD participants from the MBA and the Executive MBA programs.
Lymphatica Medtech SA
Revolution in lymphedema therapy
Website:
www.lymphaticamedtech.com/
Headquarter:
Lausanne
Foundation Date:
July 2017
Technology:
- Medtech
Sectors:
- Cancer
- Cardiovascular
- Medical devices
- Medtech
- Surgery
Support received
